The Ministry of Health Records that 3.9 Million Indonesians Have Been Vaccinated with Covid-19 Phase One Saturday, March 13, 2021 – 18:49 WIB The Ministry of Health said thatas many as 3,985,596 Indonesian residents had the Covid-19 vaccine.

The Ministry of Health stated that 3,985,596 Indonesians had received the first phase of vaccination until Saturday (13/3) at 12.00 WIB oran increase of 216,422 residents from the previous day. Based on the information received,it stated that the number of people who had received the second stage vaccination was1,454,836 or had an additional 115,474 inhabitants. Vaccination targets are 40,349,051residents and 1,468,764 residents. Also Read: The AstraZeneca Vaccine Causes Blood Clots, Here's the Response of the Covid-19 Task Force The first phase of vaccination began on January 13, 2021, which targets health workers. Meanwhile, the second phase of vaccination begins on February 17, 2021, with a total target of 38 million vaccinations, consisting of 21 million elderly people (elderly) and 16 million others are public servants. Previously, Head of the Eijkman Institute for Molecular Biology, Amin Soebandrio, said the Covid-19 vaccination program needed to be accelerated before the SARS-Cov2 virus that causes the disease to mutate more and more. Amin said, regarding the emergence of the mutation of the corona virus, there are recommendations so that as much as possible the vaccination is completed as soon as possible before the virus mutates.

Also Read: BPOM Does Not Allow Clinical Trial II of Nusantara Vaccines, Here's Bang Azis Syamsuddin Reaction "Vaccination does not necessarily stop the pandemic and it does not mean that after being vaccinated the body will be immune to the virus. The emergence of a new variant of Covid-19 is an impetus for continuing to apply health protocols," he explained. As isknown, on March 2, 2021, the Ministry of Health announced the discovery of a new variant ofSARS-Cov-2 in Indonesia which was previously found in the UK, and proven to have a faster transmission rate of up to 74 percent.

Source https://www.jpnn.com/news

Copyright RRLO 2020

IMPORTANT: This publication is intended for informational purposes only and does not constitute legal advice. Any reliance on the material contained herein is at the user’s own risk. If you need legal assistance on particular subject, you can call our firm/RRLO at our contact number. All RRLO publications are copyrighted and may not be reproduced without the express written consent of RRLO.